← SynDRA
LENUMLOSTAT
SynDRA canonical compound SYN0039300 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | LOXL2 |
|---|
| Mechanism of action | lysyl oxidase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- LOXL2 INHIBITOR
- Lysyl oxidase homolog 2 inhibitor
- lysyl oxidase inhibitor
Cross-references
Synonyms
- PAT-1251
- Pat-1251
- UNII-Y3HMF6G24B
- RefChem:170158
- LOXL2 Inhibitor GB2064
- PAT1251
- GB2064
- GB-2064
- Lysyl Oxidase-like Protein 2 Inhibitor PAT-1251
- Y3HMF6G24B
- lenumlostat [INN]
- orb1708935
- orb1739567
- SCHEMBL18072268
- SCHEMBL29395153
- SCHEMBL30403427
- ODGXXYXJORZPHE-ZIAGYGMSSA-N
- US10774069, Compound 1
- BDBM461421
- GLXC-26901
- HMS6018G22
- EX-A2634
- BDBM50266822
- MFCD31657357
- PAT-1251?
- AKOS040733975
- T12371L
- DA-56609
- DA-74952
- MS-26763
- HY-107422
- HY-152855
- CS-0028450
- CS-0641172
- G16298
- T69913
- WCLUQDIEECAJLM-DTPOWOMPSA-N
- orb1708936
- UNII-4JZ3PGD8T8
Look up LENUMLOSTAT in the interactive SynDRA portal →